July 10, 2015 – FDA approves Rexulti to treat schizophrenia and as an add-on for major depressive disorder (MDD).
Jul 2015 – Approved for schizophrenia treatment
Announcement Date: July 10, 2015
July 10, 2015 – FDA approves Rexulti to treat schizophrenia and as an add-on for major depressive disorder (MDD).